Enoxaparin and Mesalamine (Combination)

Enoxaparin and mesalamine is a combination therapy that has been studied for the treatment of active ulcerative colitis. This combination appears to be effective in reducing inflammation in the colon, with enoxaparin providing anti-inflammatory effects beyond its traditional anticoagulant properties. Studies have shown that low-dose low-molecular-weight heparin (enoxaparin) once a week, combined with mesalamine, may be an effective therapy for active ulcerative colitis and could potentially delay or preclude the need for steroid treatment[1].\n\nThe mechanism of action involves mesalamine's ability to dampen the inflammatory process through inhibition of prostaglandin synthesis, interference with leukotriene synthesis, and acting as a free radical scavenger[3]. Mesalamine works mainly topically rather than systemically in the colon[3]. Enoxaparin, when administered orally, has been shown to reduce inflammatory pathology in colitis models, potentially through its anti-inflammatory properties rather than its anticoagulant effects[4].